OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

SIOP Asia in Mongolia Was a Great Success

15 Posts Not To Miss From ASCO Breakthrough 2026

Guatemala Officially Enacts New Regulation for Comprehensive Cancer Care

Inside DeepHealth: How RadNet's AI Bet Is Reshaping the Business of Radiology

Oncology Community Welcomes Two New FDA Approvals for Breast Cancer

T-Bren Shows Early Activity Across HER2-Positive and HER2-Low Advanced Breast Cancer

Gold After Cancer: Summer Olympians Who Returned to Win Medals

Liang Cheng: Transforming the Treatment Landscape of Urothelial Carcinoma

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator (Calvert Formula)

Child-Pugh Score Calculator

ECOG Score Calculator

IBW / Adjusted Body Weight (Devine Formula)

Bone Scan Index (BSI) Tracker

Khorana Score (Cancer-Associated VTE Risk)

MASCC Risk Index Calculator (Febrile Neutropenia)

IMDC Risk Score Calculator (Metastatic RCC)

Oncotype DX Recurrence Score (RS) Categorizer

Cisplatin Cumulative Dose Toxicity Tracker

Khorana Score (Cancer-Associated VTE Risk)

Estimate VTE risk in ambulatory cancer patients using the validated Khorana score.

Khorana Score Points:

  • Very high-risk site (Stomach, Pancreas): +2
  • High-risk site (Lung, Lymphoma, Gynecologic, Bladder, Testicular): +1
  • Platelets ≥350 ×10⁹/L: +1
  • Hemoglobin <10 g/dL or ESA use: +1
  • WBC >11 ×10⁹/L: +1
  • BMI ≥35 kg/m²: +1

Risk Categories:

  • Low risk: 0 points
  • Intermediate risk: 1-2 points
  • High risk: ≥3 points